WuXi Biologics is a leading global contract research, development, and manufacturing organization (CRDMO) for biologics. They offer end-to-end solutions for antibodies, bispecifics, antibody-drug conjugates, fusion proteins, enzymes, and vaccines using both mammalian and microbial expression platforms, supporting clients from discovery through commercial manufacturing at scale. Core capabilities include flow cytometry, immunoassays, cell sorting, and bioanalytical services for biologics characterization and quality control.